{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T03:48:22Z","timestamp":1782445702200,"version":"3.54.5"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.ejmech.2022.114204","type":"journal-article","created":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T19:09:21Z","timestamp":1646334561000},"page":"114204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Exploring the structure-activity relationships of diphenylurea as an antibacterial scaffold active against methicillin- and vancomycin-resistant Staphylococcus aureus"],"prefix":"10.1016","volume":"234","author":[{"given":"Mohamed M.","family":"Elsebaie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5322-3038","authenticated-orcid":false,"given":"Hanzada T.","family":"Nour El-Din","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader S.","family":"Abutaleb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahman A.","family":"Abuelkhir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Wen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0491-1007","authenticated-orcid":false,"given":"Ahmed S.","family":"Attia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed N.","family":"Seleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3987-3680","authenticated-orcid":false,"given":"Abdelrahman S.","family":"Mayhoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.114204_bib1","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.64139","article-title":"Antimicrobial resistance and COVID-19: intersections and implications","volume":"10","author":"Knight","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.ejmech.2022.114204_bib2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1586\/eri.13.12","article-title":"Clinical relevance of the ESKAPE pathogens","volume":"11","author":"Pendleton","year":"2013","journal-title":"Expert Rev. Anti-infect. Ther."},{"key":"10.1016\/j.ejmech.2022.114204_bib3","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.2147\/IDR.S234610","article-title":"Antimicrobial resistance: implications and costs","volume":"12","author":"Dadgostar","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.ejmech.2022.114204_bib4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1128\/MMBR.00016-10","article-title":"Origins and evolution of antibiotic resistance","volume":"74","author":"Davies","year":"2010","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.ejmech.2022.114204_bib5","series-title":"Review on Antimicrobial Resistance: Tackling Drug-Resistant Infections Globally: Final Report and Recommendations, Review on Antimicrobial Resistance: Tackling Drug-Resistant Infections Globally: Final Report and Recommendations","author":"O'Neill","year":"2016"},{"key":"10.1016\/j.ejmech.2022.114204_bib6","series-title":"ISARIC (International Severe Acute Respiratory and Emerging Infections Consortium)","author":"Hassan","year":"2021"},{"key":"10.1016\/j.ejmech.2022.114204_bib7","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.cmi.2020.12.018","article-title":"Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis","volume":"27","author":"Langford","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ejmech.2022.114204_bib8","doi-asserted-by":"crossref","first-page":"E45","DOI":"10.3390\/antibiotics8020045","article-title":"Antibiotic discovery: where have we come from, where do we go?","volume":"8","author":"Ribeiro da Cunha","year":"2019","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejmech.2022.114204_bib9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13756-021-00893-z","article-title":"Antimicrobial multidrug resistance in the era of COVID-19: a forgotten plight?","volume":"10","author":"Pelfrene","year":"2021","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"10.1016\/j.ejmech.2022.114204_bib10","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nrmicro.2017.104","article-title":"The commensal lifestyle of Staphylococcus aureus and its interactions with the nasal microbiota","volume":"15","author":"Krismer","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2022.114204_bib11","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1471-2334-11-138","article-title":"MRSA prevalence in European healthcare settings: a review","volume":"11","author":"Dulon","year":"2011","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.ejmech.2022.114204_bib12","doi-asserted-by":"crossref","first-page":"5663","DOI":"10.1128\/JB.00628-10","article-title":"Role of surface protein SasG in biofilm formation by Staphylococcus aureus","volume":"192","author":"Geoghegan","year":"2010","journal-title":"J.\u00a0Bacteriol."},{"key":"10.1016\/j.ejmech.2022.114204_bib13","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/CMR.00134-14","article-title":"Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management","volume":"28","author":"Tong","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2022.114204_bib14","first-page":"2016","article-title":"Mechanisms of antimicrobial resistance in ESKAPE pathogens","author":"Santajit","year":"2016","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejmech.2022.114204_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005837","article-title":"Community-associated methicillin-resistant Staphylococcus aureus: an enemy amidst us","volume":"12","author":"Kong","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2022.114204_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/345476","article-title":"Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis","volume":"36","author":"Cosgrove","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2022.114204_bib17","series-title":"Antibiotic Resistance Threats in the United States","author":"Cdc","year":"2019"},{"key":"10.1016\/j.ejmech.2022.114204_bib18","series-title":"Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics","author":"WHO","year":"2017"},{"key":"10.1016\/j.ejmech.2022.114204_bib19","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s10096-016-2603-2","article-title":"Relationship between pathogenic, clinical, and virulence factors of Staphylococcus aureus in infective endocarditis versus uncomplicated bacteremia: a case-control study","volume":"35","author":"Gallardo-Garc\u00eda","year":"2016","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ejmech.2022.114204_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens5010022","article-title":"The role of Staphylococcus aureus virulence factors in skin infection and their potential as vaccine antigens","volume":"5","author":"Lacey","year":"2016","journal-title":"Pathogens"},{"key":"10.1016\/j.ejmech.2022.114204_bib21","first-page":"DC12","article-title":"Comparison of in-vitro activities of linezolid and vancomycin against Staphylococcus aureus isolated from a tertiary care hospital","volume":"8","author":"Kishore","year":"2014","journal-title":"J.\u00a0Clin. Diagn. Res.: J. Clin. Diagn. Res."},{"key":"10.1016\/j.ejmech.2022.114204_bib22","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.2147\/IDR.S296000","article-title":"Phenotype-genotype characterization and antibiotic-resistance correlations among colonizing and infectious rethicillin-resistant staphylococcus aureus recovered from intensive care units","volume":"14","author":"Nour El-Din","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.ejmech.2022.114204_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0034-1396906","article-title":"Combination antibiotic treatment of serious methicillin-resistant Staphylococcus aureus infections","volume":"36","author":"Davis","year":"2015","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejmech.2022.114204_bib24","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1021\/jm401905m","article-title":"Discovery and characterization of potent thiazoles versus methicillin- and vancomycin-resistant Staphylococcus aureus","volume":"57","author":"Mohammad","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114204_bib25","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ejmech.2017.08.039","article-title":"Arylthiazole antibiotics targeting intracellular methicillin-resistant Staphylococcus aureus (MRSA) that interfere with bacterial cell wall synthesis","volume":"139","author":"Eid","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114204_bib26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejmech.2018.02.031","article-title":"Alkynyl-containing phenylthiazoles: systemically active antibacterial agents effective against methicillin-resistant Staphylococcus aureus (MRSA)","volume":"148","author":"Elsebaei","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114204_bib27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejmech.2019.04.063","article-title":"Lipophilic efficient phenylthiazoles with potent undecaprenyl pyrophosphatase inhibitory activity","volume":"175","author":"Elsebaei","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114204_bib28","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1021\/acsinfecdis.8b00172","article-title":"Naphthylthiazoles: targeting multidrug-resistant and intracellular Staphylococcus aureus with biofilm disruption activity","volume":"4","author":"Hagras","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2022.114204_bib29","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.ejmech.2017.10.048","article-title":"Biphenylthiazole antibiotics with an oxadiazole linker: an approach to improve physicochemical properties and oral bioavailability","volume":"143","author":"Hagras","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114204_bib30","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1021\/acs.jmedchem.7b00392","article-title":"Investigating the antibacterial activity of biphenylthiazoles against methicillin- and vancomycin-resistant Staphylococcus aureus (MRSA and VRSA)","volume":"60","author":"Hagras","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114204_bib31","first-page":"7998","volume":"62","author":"Hammad","year":"2019"},{"key":"10.1016\/j.ejmech.2022.114204_bib32","first-page":"111830","article-title":"Modifying the lipophilic part of phenylthiazole antibiotics to control their drug","volume":"185","author":"Hosny","year":"2020","journal-title":"-likeness"},{"key":"10.1016\/j.ejmech.2022.114204_bib33","first-page":"111593","volume":"182","author":"Elsebaei","year":"2019"},{"key":"10.1016\/j.ejmech.2022.114204_bib34","first-page":"80","volume":"6","author":"Mancy","year":"2019"},{"key":"10.1016\/j.ejmech.2022.114204_bib35","first-page":"2887","article-title":"Development of biphenylthiazoles exhibiting improved pharmacokinetics and potent activity against intracellular","volume":"6","author":"Hagras","year":"2020","journal-title":"Staphylococcus aureus"},{"key":"10.1016\/j.ejmech.2022.114204_bib36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejmech.2017.02.044","article-title":"Diphenylurea derivatives for combating methicillin- and vancomycin-resistant Staphylococcus aureus","volume":"130","author":"Eissa","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114204_bib37","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.3201\/eid2111.150452","article-title":"USA300 methicillin-resistant Staphylococcus aureus, United States, 2000-2013","volume":"21","author":"Carrel","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ejmech.2022.114204_bib38","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3201\/eid1704.100482","article-title":"High rates of Staphylococcus aureus USA400 infection, Northern Canada","volume":"17","author":"Golding","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ejmech.2022.114204_bib39","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1086\/499815","article-title":"Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections","volume":"42","author":"Seybold","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2022.114204_bib40","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1086\/503777","article-title":"Roles of 34 virulence genes in the evolution of hospital- and community-associated strains of methicillin-resistant Staphylococcus aureus","volume":"193","author":"Diep","year":"2006","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ejmech.2022.114204_bib41","first-page":"998","article-title":"Methicillin-resistant Staphylococcus aureus colonization in HIV-infected outpatients is common and detection is enhanced by groin culture, Epidemiol","volume":"139","author":"Peters","year":"2011","journal-title":"Infect"},{"key":"10.1016\/j.ejmech.2022.114204_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182821","article-title":"Bacteriological profiling of diphenylureas as a novel class of antibiotics against methicillin-resistant Staphylococcus aureus","volume":"12","author":"Mohammad","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2022.114204_bib43","doi-asserted-by":"crossref","first-page":"7251","DOI":"10.1038\/s41598-020-64352-2","article-title":"Auranofin rapidly eradicates methicillin-resistant Staphylococcus aureus (MRSA) in an infected pressure ulcer mouse model","volume":"10","author":"Mohammad","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2022.114204_bib44","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/jac\/44.4.455","article-title":"Combined effects of vancomycin and imipenem against methicillin-resistant Staphylococcus aureus (MRSA) in\u00a0vitro and in\u00a0vivo","volume":"44","author":"Totsuka","year":"1999","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2022.114204_bib45","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1046\/j.1365-2672.2002.01594.x","article-title":"The antibacterial activity of vancomycin towards Staphylococcus aureus under aerobic and anaerobic conditions","volume":"92","author":"Suller","year":"2002","journal-title":"J.\u00a0Appl. Microbiol."},{"key":"10.1016\/j.ejmech.2022.114204_bib46","doi-asserted-by":"crossref","first-page":"134","DOI":"10.18683\/germs.2018.1140","article-title":"Vancomycin resistance among Staphylococcus aureus isolates in a rural setting, Egypt","volume":"8","author":"ElSayed","year":"2018","journal-title":"Germs"},{"key":"10.1016\/j.ejmech.2022.114204_bib47","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.chembiol.2012.11.013","article-title":"Discovery of wall teichoic acid inhibitors as potential anti-MRSA beta-lactam combination agents","volume":"20","author":"Wang","year":"2013","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2022.114204_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182821","article-title":"Bacteriological profiling of diphenylureas as a novel class of antibiotics against methicillin-resistant Staphylococcus aureus","volume":"12","author":"Mohammad","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2022.114204_bib49","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ja.2014.142","article-title":"Anti-biofilm activity and synergism of novel thiazole compounds with glycopeptide antibiotics against multidrug-resistant staphylococci","volume":"68","author":"Mohammad","year":"2015","journal-title":"J.\u00a0Antibiot. (Tokyo)"},{"key":"10.1016\/j.ejmech.2022.114204_bib50","series-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically","author":"CLSI","year":"2012"},{"key":"10.1016\/j.ejmech.2022.114204_bib51","doi-asserted-by":"crossref","first-page":"112497","DOI":"10.1016\/j.ejmech.2020.112497","article-title":"Evaluation of N-phenyl-2-aminothiazoles for treatment of multi-drug resistant and intracellular Staphylococcus aureus infections","volume":"202","author":"Shahin","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114204_bib52","doi-asserted-by":"crossref","first-page":"111830","DOI":"10.1016\/j.ejmech.2019.111830","article-title":"Modifying the lipophilic part of phenylthiazole antibiotics to control their drug-likeness","volume":"185","author":"Hosny","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114204_bib53","doi-asserted-by":"crossref","first-page":"700494","DOI":"10.3389\/fmicb.2021.700494","article-title":"Staquorsin: a novel Staphylococcus aureus agr-mediated quorum sensing inhibitor impairing virulence in\u00a0vivo without notable resistance development","volume":"12","author":"Mahdally","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2022.114204_bib54","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0076-6879(88)65033-6","article-title":"Assay of hemolytic toxins","volume":"165","author":"Bernheimer","year":"1988","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejmech.2022.114204_bib55","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1021\/acsinfecdis.9b00211","article-title":"Balancing physicochemical properties of phenylthiazole compounds with antibacterial potency by modifying the lipophilic side chain","volume":"6","author":"Mancy","year":"2020","journal-title":"ACS Infect. Dis."},{"issue":"Suppl D","key":"10.1016\/j.ejmech.2022.114204_bib56","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/jac\/31.suppl_D.159","article-title":"The post-antibiotic sub-MIC effect in\u00a0vitro and in\u00a0vivo","volume":"31","author":"Cars","year":"1993","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2022.114204_bib57","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1021\/acsinfecdis.0c00137","article-title":"Development of biphenylthiazoles exhibiting improved pharmacokinetics and potent activity against intracellular Staphylococcus aureus","volume":"6","author":"Hagras","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2022.114204_bib58","first-page":"e2528","article-title":"Subcutaneous infection of methicillin resistant Staphylococcus aureus (MRSA)","author":"Tseng","year":"2011","journal-title":"JoVE"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422001064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422001064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:37:26Z","timestamp":1759329446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422001064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":58,"alternative-id":["S0223523422001064"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114204","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the structure-activity relationships of diphenylurea as an antibacterial scaffold active against methicillin- and vancomycin-resistant Staphylococcus aureus","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114204","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114204"}}